MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 68 filers reported holding MIRATI THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,783,000 | -76.7% | 509,750 | -8.7% | 0.19% | -73.8% |
| Q1 2016 | $11,955,000 | +50.6% | 558,625 | +122.4% | 0.73% | +64.3% |
| Q4 2015 | $7,936,000 | -17.0% | 251,137 | -9.6% | 0.45% | +36.0% |
| Q3 2015 | $9,560,000 | +3.8% | 277,733 | -5.1% | 0.33% | +136.0% |
| Q2 2015 | $9,206,000 | -31.2% | 292,522 | -35.9% | 0.14% | -81.3% |
| Q1 2015 | $13,384,000 | +56.0% | 456,466 | -10.0% | 0.74% | +73.7% |
| Q4 2014 | $8,579,000 | +0.1% | 507,184 | 0.0% | 0.43% | -2.7% |
| Q3 2014 | $8,573,000 | -13.8% | 507,184 | 0.0% | 0.44% | -18.0% |
| Q2 2014 | $9,949,000 | -2.3% | 507,184 | -5.0% | 0.54% | -7.7% |
| Q1 2014 | $10,181,000 | +23.6% | 533,878 | -1.3% | 0.58% | +20.7% |
| Q4 2013 | $8,236,000 | +21.3% | 540,978 | -8.8% | 0.48% | +4.5% |
| Q3 2013 | $6,788,000 | – | 592,978 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |